Adrenomedullin Reduces VEGF-Induced Endothelial Adhesion Molecules and Adhesiveness Through a Phosphatidylinositol 3′-Kinase Pathway

OBJECTIVE—In the initial phase of inflammation, vascular endothelial growth factor (VEGF) can act as a proinflammatory cytokine by inducing adhesion molecules that bind leukocytes to endothelial cells. Adrenomedullin (AM) is known to act as either a proinflammatory or an anti-inflammatory agent. In...

Full description

Saved in:
Bibliographic Details
Published inArteriosclerosis, thrombosis, and vascular biology Vol. 23; no. 8; pp. 1377 - 1383
Main Authors Kim, Won, Moon, Sang-Ok, Lee, Sik, Sung, Mi Jeong, Kim, Sung Hoon, Park, Sung Kwang
Format Journal Article
LanguageEnglish
Published Philadelphia, PA American Heart Association, Inc 01.08.2003
Hagerstown, MD Lippincott
Subjects
Online AccessGet full text

Cover

Loading…
Abstract OBJECTIVE—In the initial phase of inflammation, vascular endothelial growth factor (VEGF) can act as a proinflammatory cytokine by inducing adhesion molecules that bind leukocytes to endothelial cells. Adrenomedullin (AM) is known to act as either a proinflammatory or an anti-inflammatory agent. In this study, we examined the effects of AM on adhesion molecule expression and leukocyte adhesiveness in VEGF-stimulated human umbilical vein endothelial cells. METHODS AND RESULTS—When stimulated with VEGF, the mRNAs of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin were dose-dependently upregulated. AM inhibited the VEGF-induced protein and mRNA expression of ICAM-1, VCAM-1, and E-selectin. Phosphatidylinositol 3′-kinase inhibitor and a dominant-negative form of Akt significantly inhibited the suppressive effect of AM on VEGF-induced adhesion molecule expression. Thus, AM inhibits VEGF-stimulated ICAM-1 and VCAM-1 expression through a phosphatidylinositol 3′-kinase/Akt pathway. AM reduced VEGF-induced endothelial adhesiveness for leukocytes. CONCLUSIONS—These results suggest that AM might have an anti-inflammatory role in controlling VEGF-induced adhesion molecule gene expression and adhesiveness toward leukocytes in endothelial cells.
AbstractList In the initial phase of inflammation, vascular endothelial growth factor (VEGF) can act as a proinflammatory cytokine by inducing adhesion molecules that bind leukocytes to endothelial cells. Adrenomedullin (AM) is known to act as either a proinflammatory or an anti-inflammatory agent. In this study, we examined the effects of AM on adhesion molecule expression and leukocyte adhesiveness in VEGF-stimulated human umbilical vein endothelial cells. When stimulated with VEGF, the mRNAs of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin were dose-dependently upregulated. AM inhibited the VEGF-induced protein and mRNA expression of ICAM-1, VCAM-1, and E-selectin. Phosphatidylinositol 3'-kinase inhibitor and a dominant-negative form of Akt significantly inhibited the suppressive effect of AM on VEGF-induced adhesion molecule expression. Thus, AM inhibits VEGF-stimulated ICAM-1 and VCAM-1 expression through a phosphatidylinositol 3'-kinase/Akt pathway. AM reduced VEGF-induced endothelial adhesiveness for leukocytes. These results suggest that AM might have an anti-inflammatory role in controlling VEGF-induced adhesion molecule gene expression and adhesiveness toward leukocytes in endothelial cells.
OBJECTIVE: In the initial phase of inflammation, vascular endothelial growth factor (VEGF) can act as a proinflammatory cytokine by inducing adhesion molecules that bind leukocytes to endothelial cells. Adrenomedullin (AM) is known to act as either a proinflammatory or an anti-inflammatory agent. In this study, we examined the effects of AM on adhesion molecule expression and leukocyte adhesiveness in VEGF-stimulated human umbilical vein endothelial cells. METHODS AND RESULTS: When stimulated with VEGF, the mRNAs of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin were dose-dependently upregulated. AM inhibited the VEGF-induced protein and mRNA expression of ICAM-1, VCAM-1, and E-selectin. Phosphatidylinositol 3'-kinase inhibitor and a dominant-negative form of Akt significantly inhibited the suppressive effect of AM on VEGF-induced adhesion molecule expression. Thus, AM inhibits VEGF-stimulated ICAM-1 and VCAM-1 expression through a phosphatidylinositol 3'-kinase/Akt pathway. AM reduced VEGF-induced endothelial adhesiveness for leukocytes. CONCLUSIONS: These results suggest that AM might have an anti-inflammatory role in controlling VEGF-induced adhesion molecule gene expression and adhesiveness toward leukocytes in endothelial cells.
Objective— In the initial phase of inflammation, vascular endothelial growth factor (VEGF) can act as a proinflammatory cytokine by inducing adhesion molecules that bind leukocytes to endothelial cells. Adrenomedullin (AM) is known to act as either a proinflammatory or an anti-inflammatory agent. In this study, we examined the effects of AM on adhesion molecule expression and leukocyte adhesiveness in VEGF-stimulated human umbilical vein endothelial cells. Methods and Results— When stimulated with VEGF, the mRNAs of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin were dose-dependently upregulated. AM inhibited the VEGF-induced protein and mRNA expression of ICAM-1, VCAM-1, and E-selectin. Phosphatidylinositol 3′-kinase inhibitor and a dominant-negative form of Akt significantly inhibited the suppressive effect of AM on VEGF-induced adhesion molecule expression. Thus, AM inhibits VEGF-stimulated ICAM-1 and VCAM-1 expression through a phosphatidylinositol 3′-kinase/Akt pathway. AM reduced VEGF-induced endothelial adhesiveness for leukocytes. Conclusions— These results suggest that AM might have an anti-inflammatory role in controlling VEGF-induced adhesion molecule gene expression and adhesiveness toward leukocytes in endothelial cells.
OBJECTIVEIn the initial phase of inflammation, vascular endothelial growth factor (VEGF) can act as a proinflammatory cytokine by inducing adhesion molecules that bind leukocytes to endothelial cells. Adrenomedullin (AM) is known to act as either a proinflammatory or an anti-inflammatory agent. In this study, we examined the effects of AM on adhesion molecule expression and leukocyte adhesiveness in VEGF-stimulated human umbilical vein endothelial cells.METHODS AND RESULTSWhen stimulated with VEGF, the mRNAs of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin were dose-dependently upregulated. AM inhibited the VEGF-induced protein and mRNA expression of ICAM-1, VCAM-1, and E-selectin. Phosphatidylinositol 3'-kinase inhibitor and a dominant-negative form of Akt significantly inhibited the suppressive effect of AM on VEGF-induced adhesion molecule expression. Thus, AM inhibits VEGF-stimulated ICAM-1 and VCAM-1 expression through a phosphatidylinositol 3'-kinase/Akt pathway. AM reduced VEGF-induced endothelial adhesiveness for leukocytes.CONCLUSIONSThese results suggest that AM might have an anti-inflammatory role in controlling VEGF-induced adhesion molecule gene expression and adhesiveness toward leukocytes in endothelial cells.
OBJECTIVE—In the initial phase of inflammation, vascular endothelial growth factor (VEGF) can act as a proinflammatory cytokine by inducing adhesion molecules that bind leukocytes to endothelial cells. Adrenomedullin (AM) is known to act as either a proinflammatory or an anti-inflammatory agent. In this study, we examined the effects of AM on adhesion molecule expression and leukocyte adhesiveness in VEGF-stimulated human umbilical vein endothelial cells. METHODS AND RESULTS—When stimulated with VEGF, the mRNAs of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin were dose-dependently upregulated. AM inhibited the VEGF-induced protein and mRNA expression of ICAM-1, VCAM-1, and E-selectin. Phosphatidylinositol 3′-kinase inhibitor and a dominant-negative form of Akt significantly inhibited the suppressive effect of AM on VEGF-induced adhesion molecule expression. Thus, AM inhibits VEGF-stimulated ICAM-1 and VCAM-1 expression through a phosphatidylinositol 3′-kinase/Akt pathway. AM reduced VEGF-induced endothelial adhesiveness for leukocytes. CONCLUSIONS—These results suggest that AM might have an anti-inflammatory role in controlling VEGF-induced adhesion molecule gene expression and adhesiveness toward leukocytes in endothelial cells.
Author Kim, Won
Lee, Sik
Moon, Sang-Ok
Park, Sung Kwang
Sung, Mi Jeong
Kim, Sung Hoon
AuthorAffiliation From the Department of Internal Medicine, Research Institute of Clinical Medicine, Chonbuk National University Medical School, Chonju, Republic of Korea
AuthorAffiliation_xml – name: From the Department of Internal Medicine, Research Institute of Clinical Medicine, Chonbuk National University Medical School, Chonju, Republic of Korea
Author_xml – sequence: 1
  givenname: Won
  surname: Kim
  fullname: Kim, Won
  organization: From the Department of Internal Medicine, Research Institute of Clinical Medicine, Chonbuk National University Medical School, Chonju, Republic of Korea
– sequence: 2
  givenname: Sang-Ok
  surname: Moon
  fullname: Moon, Sang-Ok
– sequence: 3
  givenname: Sik
  surname: Lee
  fullname: Lee, Sik
– sequence: 4
  givenname: Mi
  surname: Sung
  middlename: Jeong
  fullname: Sung, Mi Jeong
– sequence: 5
  givenname: Sung
  surname: Kim
  middlename: Hoon
  fullname: Kim, Sung Hoon
– sequence: 6
  givenname: Sung
  surname: Park
  middlename: Kwang
  fullname: Park, Sung Kwang
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15058351$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/12805078$$D View this record in MEDLINE/PubMed
BookMark eNpdkdtu1DAQhiNURA_wCiiqBHcJPjvhbtVuD6KICi29tbzxhKR47a2dsNo7rnigPhJPgsOutBKWLM-MvvnHmv80O3LeQZadY1RiLPAHhMvZ4qFE06mwZKgUHEtaXuIX2QnmhBVMUHGUYiTrggtGjrPTGB8TzghBr7JjTCrEkaxOst8zE8D5FZjR2t7lX1PQQMwf5tdXxa2bEpPPnfFDB7bXNp-ZDmLvXf7ZW2hGm1jtzL78ExzEmC-64MfvXa7z-87HdaeH3myTuo_94G1O__x6Lj71TkfI7_XQbfT2dfay1TbCm_17ln27mi8uboq7L9e3F7O7ouGipoXhEjOBNJfUcGjbloHEqVYLshSo4cYQyRGuMdN1BYSiJeK0llUDjdYs7egse7_TXQf_NEIc1KqPDVirHfgxKkkFYQTXCTz_D3z0Y3Dpb4qkLVZCUpSgjzuoCT7GAK1ah36lw1ZhpCarFMIqWaUOVql_VqlLnJrf7ieMy7T-Q-vemwS82wM6Ntq2QbumjweOI15RPgmxHbfxdoAQf9hxA0F1oO3QTaMZFYgXBCGKqpQW6WJK_wLM8K8d
CODEN ATVBFA
CitedBy_id crossref_primary_10_1016_j_ajpath_2017_01_014
crossref_primary_10_1016_j_canlet_2008_01_022
crossref_primary_10_1152_ajpcell_00044_2010
crossref_primary_10_1007_s00726_005_0279_5
crossref_primary_10_1016_j_yjmcc_2009_07_010
crossref_primary_10_1089_ars_2008_2204
crossref_primary_10_1002_tox_20430
crossref_primary_10_1016_j_peptides_2005_02_017
crossref_primary_10_1016_j_toxicon_2015_04_002
crossref_primary_10_1291_hypres_30_1065
crossref_primary_10_1016_j_ejim_2023_05_020
crossref_primary_10_1016_j_yjmcc_2014_02_007
crossref_primary_10_1124_mol_106_022392
crossref_primary_10_1210_en_2005_1038
crossref_primary_10_1124_pr_59_2_3
crossref_primary_10_1158_0008_5472_CAN_10_3787
crossref_primary_10_1016_j_ejim_2021_03_039
crossref_primary_10_1016_j_regpep_2010_08_003
crossref_primary_10_3390_ijms232113408
crossref_primary_10_1073_pnas_0609329103
crossref_primary_10_1253_circj_CJ_13_1579
crossref_primary_10_1016_j_pharmthera_2004_08_012
crossref_primary_10_1007_s00109_011_0739_1
Cites_doi 10.1002/jemt.10058
10.1016/S0014-5793(99)00358-0
10.1016/S0014-5793(98)00349-4
10.1016/S0006-8993(97)01430-3
10.1002/jemt.10048
10.1074/jbc.270.9.4412
10.1097/00004872-200103001-00012
10.1210/endo.140.11.7132
10.1016/S0196-9781(01)00519-8
10.1681/ASN.V134903
10.1074/jbc.273.43.27768
10.1006/bbrc.1993.1451
10.1128/IAI.66.10.4669-4675.1998
10.1023/A:1020695110648
10.1097/00004872-200103001-00013
10.1016/S0014-2999(00)00376-9
10.1016/0092-8674(94)90337-9
10.1073/pnas.94.21.11345
10.1016/0092-8674(91)90279-8
10.1097/00005344-200106000-00013
10.1126/science.1833819
10.1038/30666
10.1016/0014-5793(95)01427-6
10.1159/000056162
10.1074/jbc.M009705200
10.1111/j.1574-695X.1999.tb01250.x
10.1002/art.1780360204
10.1046/j.1365-2826.2002.00778.x
10.1159/000051544
10.1161/res.89.6.477
10.1046/j.1442-2042.2002.00468.x
10.1159/000045427
ContentType Journal Article
Copyright 2003 American Heart Association, Inc.
2004 INIST-CNRS
Copyright American Heart Association, Inc. Aug 1 2003
Copyright_xml – notice: 2003 American Heart Association, Inc.
– notice: 2004 INIST-CNRS
– notice: Copyright American Heart Association, Inc. Aug 1 2003
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
7X8
DOI 10.1161/01.ATV.0000081740.65173.D1
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
ProQuest Health & Medical Complete (Alumni)
CrossRef
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4636
EndPage 1383
ExternalDocumentID 385527441
10_1161_01_ATV_0000081740_65173_D1
12805078
15058351
00043605-200308000-00013
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
.Z2
01R
08R
0R
1J1
23N
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
55
5GY
5RE
5VS
71W
77Y
7O
7O~
AAAXR
AAMOA
AAMTA
AAPBV
AARTV
AAXQO
ABBUW
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFS
ACGOD
ACPRK
ACWDW
ACWRI
ACXNZ
ADACO
ADBBV
ADFPA
ADNKB
AE3
AENEX
AFFNX
AFUWQ
AHMBA
AHULI
AHVBC
AIJEX
AJIOK
AJNYG
AJYGW
ALMA_UNASSIGNED_HOLDINGS
AMJPA
ASCII
AWKKM
BAWUL
BOYCO
C1A
C45
CS3
DIK
DUNZO
E.X
E3Z
EBS
EJD
EX3
F2K
F2L
F2M
F2N
F5P
FL-
FRP
FW0
GJ
GX1
H0
H0~
H13
HZ
IKYAY
IN
IN~
J5H
JF9
JG8
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
LI0
N9A
N~7
N~B
N~M
O0-
O9-
OAG
OAH
OB2
OCUKA
ODA
OHASI
OK1
OL1
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OWW
OWY
OXXIT
P-K
P2P
PQEST
PQQKQ
PZZ
RAH
RHF
RIG
RLZ
RSW
S4R
S4S
V2I
WOQ
WOW
X3V
X3W
X7M
Z2
ZA5
ZGI
---
.3C
.55
.GJ
0R~
AAGIX
AAHPQ
AAQKA
AASOK
AAUGY
ABASU
ABDIG
ABQRW
ACCJW
ACILI
ADGGA
AE6
AEETU
AFDTB
AGINI
AHJKT
AHOMT
AHRYX
AJNWD
AKALU
AKULP
ALMTX
AMKUR
AMNEI
AOHHW
AYCSE
BS7
DIWNM
EEVPB
FCALG
GNXGY
GQDEL
HZ~
IKREB
IPNFZ
IQODW
OJAPA
OWU
OWV
OWX
OWZ
T8P
TEORI
TR2
TSPGW
VVN
W3M
W8F
XXN
XYM
YFH
ZZMQN
AAAAV
AAIQE
ABJNI
ADHPY
AHQNM
AINUH
CGR
CUY
CVF
ECM
EIF
NPM
AASCR
AAYXX
ABVCZ
ACXJB
AJZMW
CITATION
ERAAH
HLJTE
K9.
7X8
ID FETCH-LOGICAL-c5693-d571460a573d5efff4e71571962b60c5dd27501914a98e230b053978cecaa4173
ISSN 1079-5642
IngestDate Fri Aug 16 02:02:01 EDT 2024
Tue Aug 27 16:50:25 EDT 2024
Fri Aug 23 00:17:14 EDT 2024
Thu May 23 23:06:33 EDT 2024
Sun Oct 22 16:07:52 EDT 2023
Thu Aug 13 19:50:11 EDT 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Human
Cell culture
Vascular cell adhesion molecule 1
endothelial cells
Intercellular adhesion molecule 1
Enzyme
Pathogenesis
Transferases
Adrenomedullin
Cardiovascular disease
Adhesion
Vascular disease
Phosphatidylinositol
Vascular endothelium growth factor
Kinase
adhesion molecules
inflammation
vascular endothelial growth factor
Atherosclerosis
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c5693-d571460a573d5efff4e71571962b60c5dd27501914a98e230b053978cecaa4173
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ahajournals.org/doi/pdf/10.1161/01.ATV.0000081740.65173.D1
PMID 12805078
PQID 204286730
PQPubID 49288
PageCount 7
ParticipantIDs proquest_miscellaneous_73624219
proquest_journals_204286730
crossref_primary_10_1161_01_ATV_0000081740_65173_D1
pubmed_primary_12805078
pascalfrancis_primary_15058351
wolterskluwer_health_00043605-200308000-00013
ProviderPackageCode L-C
C45
7O~
AARTV
ADFPA
OLH
ASCII
OLG
AAMOA
ODA
ABZAD
ABBUW
JK3
ADNKB
JK8
H0~
1J1
OLV
OLU
JG8
OLW
OLZ
OLY
F2K
F2M
F2L
F2N
OHASI
AHVBC
AJNYG
FL-
KMI
K8S
OVLEI
AJIOK
OPUJH
V2I
S4R
S4S
4Q1
DUNZO
OAG
4Q2
OVDNE
4Q3
AMJPA
OAH
OVD
71W
AHULI
OB2
ACEWG
.Z2
N~7
IKYAY
OVIDH
AWKKM
40H
N~B
OUVQU
ORVUJ
X3V
X3W
ACDDN
ACWRI
BOYCO
AIJEX
AAXQO
AAMTA
AAAXR
E.X
OWW
OCUKA
OWY
01R
ACXNZ
OL1
ABXVJ
IN~
KD2
OXXIT
77Y
ACWDW
JF9
FW0
PublicationCentury 2000
PublicationDate 2003-August
PublicationDateYYYYMMDD 2003-08-01
PublicationDate_xml – month: 08
  year: 2003
  text: 2003-August
PublicationDecade 2000
PublicationPlace Philadelphia, PA
Hagerstown, MD
PublicationPlace_xml – name: Philadelphia, PA
– name: Hagerstown, MD
– name: United States
– name: Hagerstown
PublicationTitle Arteriosclerosis, thrombosis, and vascular biology
PublicationTitleAlternate Arterioscler Thromb Vasc Biol
PublicationYear 2003
Publisher American Heart Association, Inc
Lippincott
Publisher_xml – name: American Heart Association, Inc
– name: Lippincott
References e_1_3_2_26_2
e_1_3_2_27_2
(e_1_3_2_22_2) 2002; 13
e_1_3_2_28_2
(e_1_3_2_30_2) 1996; 10
e_1_3_2_29_2
(e_1_3_2_13_2) 1998; 66
e_1_3_2_20_2
e_1_3_2_21_2
e_1_3_2_23_2
e_1_3_2_24_2
e_1_3_2_25_2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_16_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
(e_1_3_2_18_2) 1999; 65
e_1_3_2_19_2
e_1_3_2_1_2
(e_1_3_2_8_2) 1996; 81
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_36_2
e_1_3_2_2_2
e_1_3_2_14_2
e_1_3_2_35_2
References_xml – ident: e_1_3_2_16_2
  doi: 10.1002/jemt.10058
– volume: 65
  start-page: L203
  year: 1999
  ident: e_1_3_2_18_2
  publication-title: Life Sci
– ident: e_1_3_2_28_2
  doi: 10.1016/S0014-5793(99)00358-0
– ident: e_1_3_2_12_2
  doi: 10.1016/S0014-5793(98)00349-4
– ident: e_1_3_2_32_2
  doi: 10.1016/S0006-8993(97)01430-3
– ident: e_1_3_2_10_2
  doi: 10.1002/jemt.10048
– ident: e_1_3_2_31_2
  doi: 10.1074/jbc.270.9.4412
– ident: e_1_3_2_34_2
  doi: 10.1097/00004872-200103001-00012
– ident: e_1_3_2_6_2
  doi: 10.1210/endo.140.11.7132
– ident: e_1_3_2_11_2
  doi: 10.1016/S0196-9781(01)00519-8
– volume: 13
  start-page: 903
  year: 2002
  ident: e_1_3_2_22_2
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.V134903
– volume: 10
  start-page: 421
  year: 1996
  ident: e_1_3_2_30_2
  publication-title: J Hum Hypertens
– ident: e_1_3_2_35_2
  doi: 10.1074/jbc.273.43.27768
– ident: e_1_3_2_4_2
  doi: 10.1006/bbrc.1993.1451
– volume: 66
  start-page: 4669
  year: 1998
  ident: e_1_3_2_13_2
  publication-title: Infect Immun
  doi: 10.1128/IAI.66.10.4669-4675.1998
– ident: e_1_3_2_21_2
  doi: 10.1023/A:1020695110648
– ident: e_1_3_2_23_2
  doi: 10.1097/00004872-200103001-00013
– ident: e_1_3_2_17_2
  doi: 10.1016/S0014-2999(00)00376-9
– ident: e_1_3_2_1_2
  doi: 10.1016/0092-8674(94)90337-9
– ident: e_1_3_2_15_2
  doi: 10.1016/S0196-9781(01)00519-8
– ident: e_1_3_2_25_2
  doi: 10.1073/pnas.94.21.11345
– ident: e_1_3_2_2_2
  doi: 10.1016/0092-8674(91)90279-8
– ident: e_1_3_2_36_2
  doi: 10.1097/00005344-200106000-00013
– ident: e_1_3_2_24_2
  doi: 10.1126/science.1833819
– ident: e_1_3_2_27_2
  doi: 10.1038/30666
– volume: 81
  start-page: 1449
  year: 1996
  ident: e_1_3_2_8_2
  publication-title: J Clin Endocrinol Metab
– ident: e_1_3_2_29_2
  doi: 10.1016/0014-5793(95)01427-6
– ident: e_1_3_2_14_2
  doi: 10.1159/000056162
– ident: e_1_3_2_19_2
  doi: 10.1074/jbc.M009705200
– ident: e_1_3_2_26_2
  doi: 10.1111/j.1574-695X.1999.tb01250.x
– ident: e_1_3_2_3_2
  doi: 10.1002/art.1780360204
– ident: e_1_3_2_5_2
  doi: 10.1046/j.1365-2826.2002.00778.x
– ident: e_1_3_2_7_2
  doi: 10.1159/000051544
– ident: e_1_3_2_20_2
  doi: 10.1161/res.89.6.477
– ident: e_1_3_2_9_2
  doi: 10.1046/j.1442-2042.2002.00468.x
– ident: e_1_3_2_33_2
  doi: 10.1159/000045427
SSID ssj0004220
Score 1.9341866
Snippet OBJECTIVE—In the initial phase of inflammation, vascular endothelial growth factor (VEGF) can act as a proinflammatory cytokine by inducing adhesion molecules...
In the initial phase of inflammation, vascular endothelial growth factor (VEGF) can act as a proinflammatory cytokine by inducing adhesion molecules that bind...
Objective— In the initial phase of inflammation, vascular endothelial growth factor (VEGF) can act as a proinflammatory cytokine by inducing adhesion molecules...
OBJECTIVE: In the initial phase of inflammation, vascular endothelial growth factor (VEGF) can act as a proinflammatory cytokine by inducing adhesion molecules...
OBJECTIVEIn the initial phase of inflammation, vascular endothelial growth factor (VEGF) can act as a proinflammatory cytokine by inducing adhesion molecules...
SourceID proquest
crossref
pubmed
pascalfrancis
wolterskluwer
SourceType Aggregation Database
Index Database
Publisher
StartPage 1377
SubjectTerms Adrenomedullin
Atherosclerosis (general aspects, experimental research)
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Cell Adhesion - physiology
Cell Adhesion Molecules - genetics
Cell Adhesion Molecules - metabolism
Cells, Cultured
E-Selectin - genetics
E-Selectin - metabolism
Endothelium, Vascular - metabolism
Enzyme Activation
Gene Expression - physiology
Humans
Intercellular Adhesion Molecule-1 - genetics
Intercellular Adhesion Molecule-1 - metabolism
Leukocytes - physiology
Medical sciences
Peptides - genetics
Peptides - metabolism
Phosphatidylinositol 3-Kinases - metabolism
Phosphorylation
Protein-Serine-Threonine Kinases
Proto-Oncogene Proteins - metabolism
Proto-Oncogene Proteins c-akt
RNA, Messenger - analysis
Signal Transduction
Vascular Cell Adhesion Molecule-1 - genetics
Vascular Cell Adhesion Molecule-1 - metabolism
Vascular Endothelial Growth Factor A - metabolism
Vasculitis - physiopathology
Title Adrenomedullin Reduces VEGF-Induced Endothelial Adhesion Molecules and Adhesiveness Through a Phosphatidylinositol 3′-Kinase Pathway
URI http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00043605-200308000-00013
https://www.ncbi.nlm.nih.gov/pubmed/12805078
https://www.proquest.com/docview/204286730/abstract/
https://search.proquest.com/docview/73624219
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBASQtwJg-EHEA9Vujj3PFZsYxoqCLUbe7Oc2KHV2qSirSZ45s_wLzkndi6VOgl4qVoncap8X87xsc_5TMgbEUW5SPzcjlKZ2WD94J1LpLSZCtMUXELuViJJo0_h6bl_dhlc9nq_O1lLm3U6yH7urCv5H1ShDXDFKtl_QLbpFBrgO-ALn4AwfP4VxkMsw8byeVzRwboUucEEq4vjDyc2xNobXNtXhcQiqznOjAs5VTg71l_oTXGVFmjWzcbq1Rv3iP5yWq6WU7iV_AG9Y3JXOe97b93IvpoV4PxQk3V6LbbWhYeYITorV_BHwf1q_QLscZHWv_CGTfqrkYBqEwEqdn5tUwNGpc4KGIvim_25qSoy6UPjWdMyNkZrNOufqdK443o2w2ty6cAZGQvs-jaqmHVNtC5JNlSMO_YW9RJ3O4KQVcUNg-HkQmtUxhB7OYMwYJE3OGLdiwDU5aKiCDhrBwbIcescm5TF-tAtctuNkgDj_I9fOsL0rltr2sKtD2--MarUmq62hkL3lvDoxTzX26nsinfgnOsSUyhWV1UFRWccNHlA7psAhg41Gx-SnioekTsjk6LxmPzaJiU1pKRdUtIOKWlNStqQkgJHaJeU1JCSCrqLlNR7ZyhJDSWfkPOT48n7U9ts9WFnQZh4tgwicNmOCCJPBirPc19FDNqS0E1DJwukxH0IUItQJLGCsDkF55FEcaYyIXx4sk_JXlEW6jmhGZMi9WHY7PueL0InVj6OcfNAOqnMU9ciXv3U-VIruvAqEg4ZdxgH2HgLG69g40fMIgdbALWXQggBUQycsF8jxo2JWHEXZyRCcKIWed0cBfuNi3KiUOVmxSMPK7RYYpFnGua2Z0MTi9hbuHNdIc2rVfzQCdAkehj4VRIRzHtxY0_75G77zr0ke-vvG_UKxtTr9KBi8x8Scsmt
link.rule.ids 315,786,790,27957,27958
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adrenomedullin+reduces+VEGF-induced+endothelial+adhesion+molecules+and+adhesiveness+through+a+phosphatidylinositol+3%27-kinase+pathway&rft.jtitle=Arteriosclerosis%2C+thrombosis%2C+and+vascular+biology&rft.au=Kim%2C+Won&rft.au=Moon%2C+Sang-Ok&rft.au=Lee%2C+Sik&rft.au=Sung%2C+Mi+Jeong&rft.date=2003-08-01&rft.eissn=1524-4636&rft.volume=23&rft.issue=8&rft.spage=1377&rft_id=info:doi/10.1161%2F01.ATV.0000081740.65173.D1&rft_id=info%3Apmid%2F12805078&rft.externalDocID=12805078
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1079-5642&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1079-5642&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1079-5642&client=summon